Announcement of Requirements and Registration for the Culture-Independent Straintyping and Characterization Challenge, 51340-51341 [2014-20428]
Download as PDF
51340
Federal Register / Vol. 79, No. 167 / Thursday, August 28, 2014 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–20477 Filed 8–27–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Announcement of Requirements and
Registration for the CultureIndependent Straintyping and
Characterization Challenge
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
pmangrum on DSK3VPTVN1PROD with NOTICES
Authority: 15 U.S.C. 3719.
Award Approving Official: Thomas R.
Frieden, MD, MPH, Director, Centers for
Disease Control and Prevention, and
Administrator, Agency for Toxic
Substances and Disease Registry.
SUMMARY: The Centers for Disease
Control and Prevention (CDC) located
within the Department of Health and
Human Services (HHS) launches a
challenge competition for the
development of a method or process to
accurately and efficiently identify,
subtype, and characterize pathogenic
microorganisms directly from clinical or
environmental samples without the
need for culture or culture-based
enrichment.
Laboratory-based infectious disease
surveillance programs, such as
PulseNet, the National Tuberculosis
Surveillance System, and the Active
Bacterial Core Surveillance program,
rely on primary culture and
microbiologic testing in community
hospital and clinical laboratories. A new
generation of non-culture-based
diagnostic tests are now beginning to
enter the marketplace offering
physicians faster results and, in some
cases, more types of information than
were previously available.
Unfortunately, these new tests do not
typically result in isolates being
available for public health purposes,
and, as their use continues to grow, it
will likely become increasingly difficult
or impossible to detect and investigate
outbreaks or other important infectious
disease trends. New laboratory
approaches that do not depend on
isolates or culture for subtyping and
characterization of microbes are needed
VerDate Mar<15>2010
14:14 Aug 27, 2014
Jkt 232001
to maintain and improve important
public health activities across a range of
pathogenic organisms.
The Culture-Independent Straintyping
and Characterization Challenge is an
opportunity to develop novel
approaches to identifying and
characterizing pathogens similar to
normal flora in a complex matrix in a
process that does not require any
culture, including pre-enrichment.
Straintyping and characterization of the
Shiga toxin-producing Escherichia coli
(STEC) from clinical stool samples
represents a significant challenge and
has been selected as the target organism
for this challenge. STEC are similar in
most respects to the commensal E. coli
that are carried in the intestinal tract of
nearly everyone. Consistent
identification, straintyping, and
characterization of pathogenic STEC
directly from a complex matrix, such as
stool, requires the consistent
identification of both a variable marker
that can be used for subtyping and a
second, more stable marker that can be
used for definitive identification.
(2) Reproducibility and stability:
Ability to return consistent,
unambiguous results from three or more
replicate specimens.
(3) Throughput parameters: Proposed
solutions should have a feasible sampleto-answer turnaround time of under 48
hours, and a per-sample reagent and
consumables cost of $100 per sample or
less. Methods should be scalable to
accommodate high-throughput testing.
(4) Portability: Data should be
objective, based on open or established
standards, and amenable for
computerized analysis and easily
disseminated between laboratories.
(5) Generalizability: While the subject
organism for this challenge is STEC,
special consideration will be given to
proposals that may be readily adapted to
a range of other pathogenic
microorganisms.
(6) Epidemiologic concordance:
Consistency of the resultant data with
the known epidemiologic context of the
specimen.
How To Enter
• Sign up for a Challenge.gov account
and become a follower of the CultureIndependent Straintyping and
Characterization Challenge at https://
www.cdc.gov/amd/cidtchallenge.
• Review the rules and guidelines of
this contest listed below and at https://
www.cdc.gov/amd/cidtchallenge.
DATES: Contestants can submit solutions
between September 2, 2014 and
November 30, 2014. Judging will take
place between December 1 and 10, 2014,
during which time additional
information, clarification or
documentation may be requested. The
winner will be notified and prize
awarded by December 15, 2014.
Contest Prizes: We will choose one
winning proposal and award $200,000
by electronic funds transfer. The winner
may need to pay Federal income taxes
on any prize money. We will follow
Internal Revenue Service withholding
and reporting requirements, where
applicable.
How Winners Will Be Selected: An
expert panel of CDC program staff with
expertise in diagnostic testing,
bioinformatics, and biotechnology who
meet the requirements of the America
COMPETES Act will evaluate all
entries. The judging panel will use the
following criteria to select a single
winning submission:
(1) Resolution and typeability: Ability
to accurately straintype and characterize
STEC at high resolution from a stool
sample matrix, without the need for
culture-based amplification.
Subject of Contest Competition: Your
entry for the Culture-Independent
Straintyping and Characterization
Challenge should describe a novel or
innovative method to straintype and
characterize pathogenic organisms, such
as STEC, directly from a complex
clinical sample, without the need for
culture or culture-based amplification.
Eligibility Rules for Participating in
the Competition: The contest is open to
everyone, with the exceptions noted
below. Participants may submit
individual proposals or work as teams.
To have a chance to win a prize in
this contest you must—
(1) Register for the contest at
CHALLENGE.GOV and follow posted
contest rules;
(2) Meet all of the requirements in this
section;
(3) Enter the contest as an individual
or as a team in which a you or all
members of the team are citizen(s) or
permanent resident(s) of the United
States; or as an entity where entities are
limited to those that are incorporated
and maintain a primary place of
business in the United States; and
(4) Federal employees may not
participate in this contest in their
official capacity. Federal employees
seeking to participate in this contest
should talk with their ethics official
before submitting a proposal.
(5) Federal grantees cannot use
Federal funds to develop COMPETES
Act challenge applications unless
consistent with the purpose of their
grant award.
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
Contest Rules and Guidelines
E:\FR\FM\28AUN1.SGM
28AUN1
pmangrum on DSK3VPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 167 / Thursday, August 28, 2014 / Notices
(6) Federal contractors cannot use
Federal funds from a contract to develop
COMPETES Act challenge applications
or to fund efforts in support of a
COMPETES Act challenge submission.
You can use Federal facilities (e.g.,
laboratories) or speak with Federal
employees during the contest only if
those same Federal facilities and
employees are equally available to
everyone participating in the contest
(for example, such availability could be
announced on a public Web site).
If laboratory work is required to
support your submission, all work
should be performed under appropriate
biosafety level 2 (BSL2) conditions, and
in accordance with standard
precautions for the handling and
processing of clinical specimens.
By participating in this contest,
contestants agree to assume any and all
risks and waive claims against the
Federal Government and its related
entities, except in the case of willful
misconduct, for any injury, death,
damage, or loss of property, revenue, or
profits, whether direct, indirect, or
consequential, arising from
participation in this prize contest,
whether the injury, death, damage, or
loss arises through negligence or
otherwise. By participating in this
contest, contestants agree to indemnify
the Federal Government against third
party claims for damages arising from or
related to contest activities.
Contestants warrant that their
submissions are wholly original and do
not infringe upon any rights of any third
party of which Contestants are aware.
Registration Process for Participants:
All participants for the CultureIndependent Straintyping and
Characterization Challenge must register
before submitting a proposal.
Registration instructions are available at
https://www.cdc.gov/amd/cidtchallenge.
Deadline for registration is October 1,
2014.
Additional Information: More
information on or about CDC’s
Advanced Molecular Detection and
Response to Outbreaks of Infectious
Diseases initiative can be found at:
www.cdc.gov/amd.
Regarding Copyright/Intellectual
Property: When you submit your entry,
you must certify that you are the person
who developed the submission and that
you maintain intellectual property
rights to the process and solution that
you propose. You also must ensure that
you did not use any copyrighted
material or affect the rights of any third
party to the best of your knowledge.
Submission Rights: Once you submit
your solution, you give HHS/CDC
permission to review and evaluate your
VerDate Mar<15>2010
14:14 Aug 27, 2014
Jkt 232001
submission, and to post and share
information about your solution in the
context of the contest, its participants
and its awardee. You cannot take this
permission back or ask us for money to
use your submission for these purposes.
You can, however, give other people
permission to use your method or
solution to this challenge while the
contest is ongoing, and may keep all
other intellectual property rights to your
solution and your work.
Compliance With Rules and
Contacting Contest Winners: In order to
win the contest, you must meet all terms
and conditions of these Official Rules.
You can be named a winner only if you
meet all the requirements. We will
contact the winner using the contact
information provided (by email,
telephone, or mail after the date of the
judging). You may need to pay Federal
income taxes on any prize money. The
Department of Health and Human
Services will follow the Internal
Revenue Service withholding and
reporting requirements, where
applicable.
Privacy: If you provide personal
information to use when you register for
the contest at the Challenge.gov Web
site, we will use that information to
contact you about your entry, and to
announce updates and the final contest
winner. We will not use the information
for commercial marketing.
General Conditions: HHS/CDC can
cancel, suspend, or change the contest,
or any part of it, for any reason.
Dated: August 22, 2014.
Ron A. Otten,
Acting Deputy Associate Director for Science,
Centers for Disease Control and Prevention.
[FR Doc. 2014–20428 Filed 8–27–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2003–D–0128 (Legacy ID:
FDA–2003D–0236)]
Guidance for Industry:
Recommendations for Screening,
Testing, and Management of Blood
Donors and Blood and Blood
Components Based on Screening
Tests for Syphilis; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing the
availability of a document entitled
‘‘Guidance for Industry:
SUMMARY:
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
51341
Recommendations for Screening,
Testing, and Management of Blood
Donors and Blood and Blood
Components Based on Screening Tests
for Syphilis,’’ dated September 2014.
The guidance document provides
recommendations for screening and
testing of donors and management of
donations based on screening tests for
syphilis. The guidance is intended for
blood establishments that collect Whole
Blood or blood components, including
Source Plasma. The guidance
announced in this notice finalizes the
draft guidance of the same title, dated
March 2013 (2013 draft guidance), and
supersedes the memorandum of
December 12, 1991, entitled
‘‘Clarification of FDA Recommendations
for Donor Deferral and Product
Distribution Based on the Results of
Syphilis Testing.’’
DATES: Submit either electronic or
written comments on Agency guidances
at any time.
ADDRESSES: Submit written requests for
single copies of the guidance to the
Office of Communication, Outreach and
Development, Center for Biologics
Evaluation and Research (CBER), Food
and Drug Administration, 10903 New
Hampshire Ave., Bldg. 71, Rm. 3128,
Silver Spring, MD 20993–0002. Send
one self-addressed adhesive label to
assist the office in processing your
requests. The guidance may also be
obtained by mail by calling CBER at 1–
800–835–4709 or 240–402–7800. See
the SUPPLEMENTARY INFORMATION section
for electronic access to the guidance
document.
Submit electronic comments on the
guidance to https://www.regulations.gov.
Submit written comments to the
Division of Dockets Management (HFA–
305), Food and Drug Administration,
5630 Fishers Lane, Rm. 1061, Rockville,
MD 20852.
FOR FURTHER INFORMATION CONTACT: Paul
E. Levine, Jr., Center for Biologics
Evaluation and Research, Food and
Drug Administration, Document Control
Center, 10903 New Hampshire Ave.,
Bldg. 71, Rm. G112, Silver Spring, MD
20993–0002, 240–402–7911.
SUPPLEMENTARY INFORMATION:
I. Background
FDA is announcing the availability of
a document entitled, ‘‘Guidance for
Industry: Recommendations for
Screening, Testing, and Management of
Blood Donors and Blood and Blood
Components Based on Screening Tests
for Syphilis,’’ dated September 2014.
The guidance document provides
recommendations for screening and
testing of donors and management of
E:\FR\FM\28AUN1.SGM
28AUN1
Agencies
[Federal Register Volume 79, Number 167 (Thursday, August 28, 2014)]
[Notices]
[Pages 51340-51341]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-20428]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Announcement of Requirements and Registration for the Culture-
Independent Straintyping and Characterization Challenge
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
Authority: 15 U.S.C. 3719.
Award Approving Official: Thomas R. Frieden, MD, MPH, Director,
Centers for Disease Control and Prevention, and Administrator, Agency
for Toxic Substances and Disease Registry.
SUMMARY: The Centers for Disease Control and Prevention (CDC) located
within the Department of Health and Human Services (HHS) launches a
challenge competition for the development of a method or process to
accurately and efficiently identify, subtype, and characterize
pathogenic microorganisms directly from clinical or environmental
samples without the need for culture or culture-based enrichment.
Laboratory-based infectious disease surveillance programs, such as
PulseNet, the National Tuberculosis Surveillance System, and the Active
Bacterial Core Surveillance program, rely on primary culture and
microbiologic testing in community hospital and clinical laboratories.
A new generation of non-culture-based diagnostic tests are now
beginning to enter the marketplace offering physicians faster results
and, in some cases, more types of information than were previously
available. Unfortunately, these new tests do not typically result in
isolates being available for public health purposes, and, as their use
continues to grow, it will likely become increasingly difficult or
impossible to detect and investigate outbreaks or other important
infectious disease trends. New laboratory approaches that do not depend
on isolates or culture for subtyping and characterization of microbes
are needed to maintain and improve important public health activities
across a range of pathogenic organisms.
The Culture-Independent Straintyping and Characterization Challenge
is an opportunity to develop novel approaches to identifying and
characterizing pathogens similar to normal flora in a complex matrix in
a process that does not require any culture, including pre-enrichment.
Straintyping and characterization of the Shiga toxin-producing
Escherichia coli (STEC) from clinical stool samples represents a
significant challenge and has been selected as the target organism for
this challenge. STEC are similar in most respects to the commensal E.
coli that are carried in the intestinal tract of nearly everyone.
Consistent identification, straintyping, and characterization of
pathogenic STEC directly from a complex matrix, such as stool, requires
the consistent identification of both a variable marker that can be
used for subtyping and a second, more stable marker that can be used
for definitive identification.
How To Enter
Sign up for a Challenge.gov account and become a follower
of the Culture-Independent Straintyping and Characterization Challenge
at https://www.cdc.gov/amd/cidtchallenge.
Review the rules and guidelines of this contest listed
below and at https://www.cdc.gov/amd/cidtchallenge.
DATES: Contestants can submit solutions between September 2, 2014 and
November 30, 2014. Judging will take place between December 1 and 10,
2014, during which time additional information, clarification or
documentation may be requested. The winner will be notified and prize
awarded by December 15, 2014.
Contest Prizes: We will choose one winning proposal and award
$200,000 by electronic funds transfer. The winner may need to pay
Federal income taxes on any prize money. We will follow Internal
Revenue Service withholding and reporting requirements, where
applicable.
How Winners Will Be Selected: An expert panel of CDC program staff
with expertise in diagnostic testing, bioinformatics, and biotechnology
who meet the requirements of the America COMPETES Act will evaluate all
entries. The judging panel will use the following criteria to select a
single winning submission:
(1) Resolution and typeability: Ability to accurately straintype
and characterize STEC at high resolution from a stool sample matrix,
without the need for culture-based amplification.
(2) Reproducibility and stability: Ability to return consistent,
unambiguous results from three or more replicate specimens.
(3) Throughput parameters: Proposed solutions should have a
feasible sample-to-answer turnaround time of under 48 hours, and a per-
sample reagent and consumables cost of $100 per sample or less. Methods
should be scalable to accommodate high-throughput testing.
(4) Portability: Data should be objective, based on open or
established standards, and amenable for computerized analysis and
easily disseminated between laboratories.
(5) Generalizability: While the subject organism for this challenge
is STEC, special consideration will be given to proposals that may be
readily adapted to a range of other pathogenic microorganisms.
(6) Epidemiologic concordance: Consistency of the resultant data
with the known epidemiologic context of the specimen.
Contest Rules and Guidelines
Subject of Contest Competition: Your entry for the Culture-
Independent Straintyping and Characterization Challenge should describe
a novel or innovative method to straintype and characterize pathogenic
organisms, such as STEC, directly from a complex clinical sample,
without the need for culture or culture-based amplification.
Eligibility Rules for Participating in the Competition: The contest
is open to everyone, with the exceptions noted below. Participants may
submit individual proposals or work as teams.
To have a chance to win a prize in this contest you must--
(1) Register for the contest at CHALLENGE.GOV and follow posted
contest rules;
(2) Meet all of the requirements in this section;
(3) Enter the contest as an individual or as a team in which a you
or all members of the team are citizen(s) or permanent resident(s) of
the United States; or as an entity where entities are limited to those
that are incorporated and maintain a primary place of business in the
United States; and
(4) Federal employees may not participate in this contest in their
official capacity. Federal employees seeking to participate in this
contest should talk with their ethics official before submitting a
proposal.
(5) Federal grantees cannot use Federal funds to develop COMPETES
Act challenge applications unless consistent with the purpose of their
grant award.
[[Page 51341]]
(6) Federal contractors cannot use Federal funds from a contract to
develop COMPETES Act challenge applications or to fund efforts in
support of a COMPETES Act challenge submission.
You can use Federal facilities (e.g., laboratories) or speak with
Federal employees during the contest only if those same Federal
facilities and employees are equally available to everyone
participating in the contest (for example, such availability could be
announced on a public Web site).
If laboratory work is required to support your submission, all work
should be performed under appropriate biosafety level 2 (BSL2)
conditions, and in accordance with standard precautions for the
handling and processing of clinical specimens.
By participating in this contest, contestants agree to assume any
and all risks and waive claims against the Federal Government and its
related entities, except in the case of willful misconduct, for any
injury, death, damage, or loss of property, revenue, or profits,
whether direct, indirect, or consequential, arising from participation
in this prize contest, whether the injury, death, damage, or loss
arises through negligence or otherwise. By participating in this
contest, contestants agree to indemnify the Federal Government against
third party claims for damages arising from or related to contest
activities.
Contestants warrant that their submissions are wholly original and
do not infringe upon any rights of any third party of which Contestants
are aware.
Registration Process for Participants: All participants for the
Culture-Independent Straintyping and Characterization Challenge must
register before submitting a proposal. Registration instructions are
available at https://www.cdc.gov/amd/cidtchallenge. Deadline for
registration is October 1, 2014.
Additional Information: More information on or about CDC's Advanced
Molecular Detection and Response to Outbreaks of Infectious Diseases
initiative can be found at: www.cdc.gov/amd.
Regarding Copyright/Intellectual Property: When you submit your
entry, you must certify that you are the person who developed the
submission and that you maintain intellectual property rights to the
process and solution that you propose. You also must ensure that you
did not use any copyrighted material or affect the rights of any third
party to the best of your knowledge.
Submission Rights: Once you submit your solution, you give HHS/CDC
permission to review and evaluate your submission, and to post and
share information about your solution in the context of the contest,
its participants and its awardee. You cannot take this permission back
or ask us for money to use your submission for these purposes. You can,
however, give other people permission to use your method or solution to
this challenge while the contest is ongoing, and may keep all other
intellectual property rights to your solution and your work.
Compliance With Rules and Contacting Contest Winners: In order to
win the contest, you must meet all terms and conditions of these
Official Rules. You can be named a winner only if you meet all the
requirements. We will contact the winner using the contact information
provided (by email, telephone, or mail after the date of the judging).
You may need to pay Federal income taxes on any prize money. The
Department of Health and Human Services will follow the Internal
Revenue Service withholding and reporting requirements, where
applicable.
Privacy: If you provide personal information to use when you
register for the contest at the Challenge.gov Web site, we will use
that information to contact you about your entry, and to announce
updates and the final contest winner. We will not use the information
for commercial marketing.
General Conditions: HHS/CDC can cancel, suspend, or change the
contest, or any part of it, for any reason.
Dated: August 22, 2014.
Ron A. Otten,
Acting Deputy Associate Director for Science, Centers for Disease
Control and Prevention.
[FR Doc. 2014-20428 Filed 8-27-14; 8:45 am]
BILLING CODE 4163-18-P